The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix
Biotech stocks found themselves among gains in the week ended Sept. 18, with conference presentations, IPO news flow and updates on coronavirus vaccine/antibody candidates catalyzing some strong moves.